Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Basal insulin reduction timing for exercise in T1D
NCT03349489Unknown
- Sponsor
- McGill University Health Centre
- Start
- May 2018
- Primary completion
- Jan 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Open-label trial of human insulin in type 1 diabetes mellitus (T1D), sponsored by McGill University Health Centre. Primary endpoint: Decrease in glucose levels. Status: unknown.
02
Drugs
human insulin
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT03349489.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03349489.